Robert Leong

2.5k total citations
14 papers, 954 citations indexed

About

Robert Leong is a scholar working on Hematology, Genetics and Nephrology. According to data from OpenAlex, Robert Leong has authored 14 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hematology, 11 papers in Genetics and 3 papers in Nephrology. Recurrent topics in Robert Leong's work include Erythropoietin and Anemia Treatment (13 papers), Hemoglobinopathies and Related Disorders (9 papers) and Iron Metabolism and Disorders (8 papers). Robert Leong is often cited by papers focused on Erythropoietin and Anemia Treatment (13 papers), Hemoglobinopathies and Related Disorders (9 papers) and Iron Metabolism and Disorders (8 papers). Robert Leong collaborates with scholars based in United States, Sweden and Australia. Robert Leong's co-authors include Kin-Hung P. Yu, Thomas B. Neff, Anatole Besarab, Stefan Hemmerich, Robert Provenzano, Khalil G. Saikali, Tyson Lee, Lynda A. Szczech, Stephen J. Klaus and Joachim Hertel and has published in prestigious journals such as Blood, Journal of the American Society of Nephrology and Clinical Journal of the American Society of Nephrology.

In The Last Decade

Robert Leong

14 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert Leong United States	9	683	322	293	271	169	14	954
Kin-Hung P. Yu United States	8	605 0.9×	304 0.9×	259 0.9×	246 0.9×	153 0.9×	19	1.1k
Tyson Lee United States	7	313 0.5×	207 0.6×	149 0.5×	195 0.7×	74 0.4×	10	670
Steven Zeig United States	11	637 0.9×	146 0.5×	275 0.9×	751 2.8×	106 0.6×	23	1.2k
ST Koury United States	7	750 1.1×	180 0.6×	280 1.0×	70 0.3×	101 0.6×	8	1.1k
MJ Koury United States	9	761 1.1×	183 0.6×	287 1.0×	71 0.3×	102 0.6×	13	1.1k
Delyth Jones United Kingdom	8	265 0.4×	105 0.3×	96 0.3×	157 0.6×	71 0.4×	11	522
Udaya Valluri United States	7	228 0.3×	60 0.2×	90 0.3×	95 0.4×	70 0.4×	15	380
Sara C. Meyer Switzerland	18	531 0.8×	66 0.2×	437 1.5×	31 0.1×	29 0.2×	44	965
James McKenney United States	9	206 0.3×	62 0.2×	85 0.3×	20 0.1×	25 0.1×	17	652
Ann Van Campenhout Belgium	11	91 0.1×	52 0.2×	51 0.2×	96 0.4×	15 0.1×	14	680

Countries citing papers authored by Robert Leong

Since Specialization

Citations

This map shows the geographic impact of Robert Leong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Leong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Leong more than expected).

Fields of papers citing papers by Robert Leong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Leong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Leong. The network helps show where Robert Leong may publish in the future.

Co-authorship network of co-authors of Robert Leong

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Leong. A scholar is included among the top collaborators of Robert Leong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Leong. Robert Leong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Pérgola, Pablo E., Chaim Charytan, Dustin J. Little, et al.. (2022). Changes in Iron Availability with Roxadustat in Nondialysis- and Dialysis-Dependent Patients with Anemia of CKD. Kidney360. 3(9). 1511–1528. 13 indexed citations

Charytan, Chaim, Edouard Martin, Dylan Steer, et al.. (2021). A Randomized Trial of Roxadustat in Anemia of Kidney Failure: SIERRAS Study. Kidney International Reports. 6(7). 1829–1839. 67 indexed citations

Provenzano, Robert, Lynda A. Szczech, Robert Leong, et al.. (2021). Efficacy and Cardiovascular Safety of Roxadustat for Treatment of Anemia in Patients with Non–Dialysis-Dependent CKD. Clinical Journal of the American Society of Nephrology. 16(8). 1190–1200. 56 indexed citations

Provenzano, Robert, Steven Fishbane, Pablo E. Pérgola, et al.. (2021). POS-284 CARDIOVASCULAR OUTCOMES AND EXPLORATORY ANALYSES BY ACHIEVED HB LEVELS IN POOLED PHASE 3 TRIALS OF ROXADUSTAT IN DIALYSIS-DEPENDENT PATIENTS WITH ANEMIA OF CHRONIC KIDNEY DISEASE. Kidney International Reports. 6(4). S121–S121. 1 indexed citations

Provenzano, Robert, Evgeny Shutov, Lona Poole, et al.. (2021). Roxadustat for anemia in patients with end-stage renal disease incident to dialysis. Nephrology Dialysis Transplantation. 36(9). 1717–1730. 85 indexed citations

Henry, David H., John A. Glaspy, Rosemary Harrup, et al.. (2021). Roxadustat for the treatment of anemia in patients with lower‐risk myelodysplastic syndrome: Open‐label, dose‐selection, lead‐in stage of a phase 3 study. American Journal of Hematology. 97(2). 174–184. 42 indexed citations

Pérgola, Pablo E., Chaim Charytan, Dustin J. Little, et al.. (2021). POS-283 HEMOGLOBIN (HB) CORRECTION WITH ROXADUSTAT IS ASSOCIATED WITH IMPROVED IRON HOMEOSTASIS IN PATIENTS WITH NON-DIALYSIS-DEPENDENT (NDD) AND DIALYSIS-DEPENDENT (DD) CHRONIC KIDNEY DISEASE (CKD). Kidney International Reports. 6(4). S120–S121. 1 indexed citations

Henry, David H., John A. Glaspy, Rosemary Harrup, et al.. (2020). Oral Roxadustat Demonstrates Efficacy in Anemia Secondary to Lower-Risk Myelodysplastic Syndrome Irrespective of Ring Sideroblasts and Baseline Erythropoietin Levels. Blood. 136(Supplement 1). 29–30. 4 indexed citations

Coyne, Daniel W., Steven Fishbane, Pablo E. Pérgola, et al.. (2020). Roxadustat Is Not Associated with an Increased Risk of Neoplasm in Patients with CKD and Anemia. Journal of the American Society of Nephrology. 31(10S). 1–2. 3 indexed citations

10.

Fishbane, Steven, et al.. (2020). Hemoglobin (Hb) Correction with Roxadustat Is Associated with Improved Iron Homeostasis in Patients with Non-Dialysis-Dependent CKD (NDD-CKD). Journal of the American Society of Nephrology. 31(10S). 130–130. 1 indexed citations

11.

Henry, David H., John A. Glaspy, Rosemary Harrup, et al.. (2019). Roxadustat (FG4592; ASP1517; AZD9941) in the Treatment of Anemia in Patients with Lower Risk Myelodysplastic Syndrome (LR-MDS) and Low Red Blood Cell (RBC) Transfusion Burden (LTB). Blood. 134(Supplement_1). 843–843. 16 indexed citations

12.

Provenzano, Robert, Anatole Besarab, Chao Sun, et al.. (2016). Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD. Clinical Journal of the American Society of Nephrology. 11(6). 982–991. 223 indexed citations

13.

Besarab, Anatole, Е. А. Chernyavskaya, Evgeny Shutov, et al.. (2015). Roxadustat (FG-4592). Journal of the American Society of Nephrology. 27(4). 1225–1233. 210 indexed citations

14.

Besarab, Anatole, Robert Provenzano, Joachim Hertel, et al.. (2015). Randomized placebo-controlled dose-ranging and pharmacodynamics study of roxadustat (FG-4592) to treat anemia in nondialysis-dependent chronic kidney disease (NDD-CKD) patients. Nephrology Dialysis Transplantation. 30(10). 1665–1673. 232 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact